Swiss stocks - Factors to watch on April 15

Reuters

04-15

Swiss stocks - Factors to watch on April 15

ZURICH/GDANSK, April 15 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday:

UBS UBSG.S

UBS has downgraded its China GDP growth forecast to 3.4% for 2025, on the assumption that tariff hikes between it and the United States will remain in place and that Beijing will roll out additional stimulus, it said in a report on Tuesday.

SIKA SIKA.S

Swiss construction chemicals maker Sika on Tuesday reported first-quarter sales that narrowly missed estimates and maintained its outlook for 2025, saying it was not directly affected by U.S. tariffs.

SANDOZ SDZ.S

The Swiss generic drug manufacturer said on Monday it had filed an antitrust lawsuit in the United States against Amgen over the alleged entrenchment of the market position of its blockbuster medicine, Enbrel (etanercept).

COMPANY STATEMENTS

SULZER SUN.S

Says Q1 Order Intake Stable, Confirms Guidance

ANNUAL GENERAL MEETINGS

SANDOZ GROUP SDZ.S - 0.6 CHF/shr dividend proposed

EX-DIVIDEND

SWISS RE SRENH.S - 6.61 CHF/shr dividend

UBS GROUP UBSG.S - 0.81 CHF/shr dividend

ECONOMY

No major Swiss economic data scheduled.

(Reporting by Zurich newsroom and Gdansk newsroom)

((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))

For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH  
All equity news E

SPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2527436506"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527436506\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2527436506?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-15 13:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527436506","market":"nz","top_or_hot":-1,"title":"Swiss stocks - Factors to watch on April 15","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Swiss stocks - Factors to watch on April 15</title></head><body><p>\n<span>ZURICH/GDANSK, April 15 (Reuters)</span><span> - </span>Here are some of the main factors that may affect Swiss stocks on Tuesday:</p><p>UBS <span>UBSG.S</span> </p><p>UBS has downgraded its China GDP growth <span>forecast</span> to 3.4% for 2025, on the assumption that tariff hikes between it and the United States will remain in place and that Beijing will roll out additional stimulus, it said in a report on Tuesday.</p><p>SIKA <span>SIKA.S</span></p><p>Swiss construction chemicals maker Sika on Tuesday reported <span>first-quarter sales</span> that narrowly missed estimates and maintained its outlook for 2025, saying it was not directly affected by U.S. tariffs.</p><p>SANDOZ <span>SDZ.S</span> </p><p>The Swiss generic drug manufacturer said on Monday it had filed an antitrust <span>lawsuit</span> in the United States against Amgen over the alleged entrenchment of the market position of its blockbuster medicine, Enbrel (etanercept).</p><p>COMPANY STATEMENTS</p><p>SULZER <span>SUN.S</span> </p><p><span>Says</span> Q1 Order Intake Stable, Confirms Guidance</p><p>ANNUAL GENERAL MEETINGS</p><p>SANDOZ GROUP <span>SDZ.S</span> - 0.6 CHF/shr dividend proposed </p><p>EX-DIVIDEND</p><p>SWISS RE <span>SRENH.S</span> - 6.61 CHF/shr dividend</p><p>UBS GROUP <span>UBSG.S</span> - 0.81 CHF/shr dividend</p><p>ECONOMY</p><p>No major Swiss economic data scheduled.</p><p> (Reporting by Zurich newsroom and Gdansk newsroom)</p><p> ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))</p><div><pre>For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g<br/><br/>FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:<br/>Daily Swiss stock market report in German <span>.SDE</span><br/>All SMI constituent stocks <span>0#.SSMI</span><br/>DJ STOXX index <span>.STOXX</span><br/>Top 10 STOXX sectors <span>.PGL.STOXXS</span><br/>Top 10 EUROSTOXX sectors <span>.PGL.STOXXES</span><br/><br/>Swiss mid-cap index <span>.SSMI</span><br/>Swiss all-share index <span>.SSHI</span><br/>Swiss market digest <span>.AD.S</span><br/>Sector overview <span>CH/SECTOR1</span><br/>All Swiss news <span>CH</span><br/>Swiss research news <span>CH-RCH</span>  <br/>All equity news <span>E</span><br/><br/>SPEED GUIDES:  <span>EQUITY</span>, <span>EQUITY/NEWS1</span>, <span>EUR/EQUITY</span>, <span>SWITZERLAND</span>, <span>REUTERS</span> \n</pre></div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Swiss stocks - Factors to watch on April 15</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSwiss stocks - Factors to watch on April 15\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-04-15 13:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Swiss stocks - Factors to watch on April 15</title></head><body><p>\n<span>ZURICH/GDANSK, April 15 (Reuters)</span><span> - </span>Here are some of the main factors that may affect Swiss stocks on Tuesday:</p><p>UBS <span>UBSG.S</span> </p><p>UBS has downgraded its China GDP growth <span>forecast</span> to 3.4% for 2025, on the assumption that tariff hikes between it and the United States will remain in place and that Beijing will roll out additional stimulus, it said in a report on Tuesday.</p><p>SIKA <span>SIKA.S</span></p><p>Swiss construction chemicals maker Sika on Tuesday reported <span>first-quarter sales</span> that narrowly missed estimates and maintained its outlook for 2025, saying it was not directly affected by U.S. tariffs.</p><p>SANDOZ <span>SDZ.S</span> </p><p>The Swiss generic drug manufacturer said on Monday it had filed an antitrust <span>lawsuit</span> in the United States against Amgen over the alleged entrenchment of the market position of its blockbuster medicine, Enbrel (etanercept).</p><p>COMPANY STATEMENTS</p><p>SULZER <span>SUN.S</span> </p><p><span>Says</span> Q1 Order Intake Stable, Confirms Guidance</p><p>ANNUAL GENERAL MEETINGS</p><p>SANDOZ GROUP <span>SDZ.S</span> - 0.6 CHF/shr dividend proposed </p><p>EX-DIVIDEND</p><p>SWISS RE <span>SRENH.S</span> - 6.61 CHF/shr dividend</p><p>UBS GROUP <span>UBSG.S</span> - 0.81 CHF/shr dividend</p><p>ECONOMY</p><p>No major Swiss economic data scheduled.</p><p> (Reporting by Zurich newsroom and Gdansk newsroom)</p><p> ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))</p><div><pre>For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g<br/><br/>FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:<br/>Daily Swiss stock market report in German <span>.SDE</span><br/>All SMI constituent stocks <span>0#.SSMI</span><br/>DJ STOXX index <span>.STOXX</span><br/>Top 10 STOXX sectors <span>.PGL.STOXXS</span><br/>Top 10 EUROSTOXX sectors <span>.PGL.STOXXES</span><br/><br/>Swiss mid-cap index <span>.SSMI</span><br/>Swiss all-share index <span>.SSHI</span><br/>Swiss market digest <span>.AD.S</span><br/>Sector overview <span>CH/SECTOR1</span><br/>All Swiss news <span>CH</span><br/>Swiss research news <span>CH-RCH</span>  <br/>All equity news <span>E</span><br/><br/>SPEED GUIDES:  <span>EQUITY</span>, <span>EQUITY/NEWS1</span>, <span>EUR/EQUITY</span>, <span>SWITZERLAND</span>, <span>REUTERS</span> \n</pre></div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0289739699.SGD","symbol_name":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL8N3QS0WN:1","article_id":"2527436506","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527436506","pubTimestamp":1744693963,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Swiss stocks - Factors to watch on April 15 ZURICH/GDANSK, April 15 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday:UBS UBSG.S UBS has downgraded its China GDP gr","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU0058720904.USD":"联博国际健康护理基金A","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","BK4599":"减肥药","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","BK4139":"生物科技","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0122379950.USD":"贝莱德世界健康科学A2","AMGN":"安进","BK4566":"资本集团","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU2242652126.USD":"FIDELITY FUNDS GLOBAL DIVIDENDS PLUS \"A\" (USD) INC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","BK4588":"碎股","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU2242646821.SGD":"Fidelity Global Dividend Plus A-MINCOME(G)-SGD","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","BK4581":"高盛持仓","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc"},"translate_title":"瑞士股市-4月15日值得关注的因素","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AMGN":0.9},"content_text":"Swiss stocks - Factors to watch on April 15\nZURICH/GDANSK, April 15 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday:UBS UBSG.S UBS has downgraded its China GDP growth forecast to 3.4% for 2025, on the assumption that tariff hikes between it and the United States will remain in place and that Beijing will roll out additional stimulus, it said in a report on Tuesday.SIKA SIKA.SSwiss construction chemicals maker Sika on Tuesday reported first-quarter sales that narrowly missed estimates and maintained its outlook for 2025, saying it was not directly affected by U.S. tariffs.SANDOZ SDZ.S The Swiss generic drug manufacturer said on Monday it had filed an antitrust lawsuit in the United States against Amgen over the alleged entrenchment of the market position of its blockbuster medicine, Enbrel (etanercept).COMPANY STATEMENTSSULZER SUN.S Says Q1 Order Intake Stable, Confirms GuidanceANNUAL GENERAL MEETINGSSANDOZ GROUP SDZ.S - 0.6 CHF/shr dividend proposed EX-DIVIDENDSWISS RE SRENH.S - 6.61 CHF/shr dividendUBS GROUP UBSG.S - 0.81 CHF/shr dividendECONOMYNo major Swiss economic data scheduled. (Reporting by Zurich newsroom and Gdansk newsroom) ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6gFOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:Daily Swiss stock market report in German .SDEAll SMI constituent stocks 0#.SSMIDJ STOXX index .STOXXTop 10 STOXX sectors .PGL.STOXXSTop 10 EUROSTOXX sectors .PGL.STOXXESSwiss mid-cap index .SSMISwiss all-share index .SSHISwiss market digest .AD.SSector overview CH/SECTOR1All Swiss news CHSwiss research news CH-RCH  All equity news ESPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}